StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Should have Halted Trading Until AFTER Q4 Report Posted

<< Previous

Bullboard Posts

Next >>

Post by Str8Shuteron Apr 01, 2021 9:47am

189 Views

Post# 32921901

Should have Halted Trading Until AFTER Q4 Report Posted

Due to the "technical difficulty" in getting the Q4 report published on SEDAR, they should have requested a trading halt until the issue was resolved and the report posted for all to digest. IMHO.

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program